Date: Tuesday, October 31, 2017
Time: 18:00 - 19:30
Venue: Tokyo American Club
Speaker: David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company
Hosting Committee: Healthcare
Member Fee: ¥7,900
Guest Fee: ¥9,900
Meal: Light Refreshment
Registration/Cancellation Deadline: Thursday, October 26, 17:00
We stand on the edge of a new Golden Age of biomedical advancements that could surpass the development of penicillin and allow us to live longer, healthier lives. In an evening keynote address, David A. Ricks, the President, CEO and Chairman of the Board of Eli Lilly and Company will discuss the promise of this new age of biomedical advancements and the preconditions in the innovation ecosystem that are needed to realize its promise as well as Japan’s place in it.
Eli Lilly and Company, which is focused solely on innovative biomedical research, has been doing business in Japan for over 100 years.
Mr. Ricks' keynote address will be followed by a moderated question and answer session that will also be open to the press.
For information about the speaker, please click here.
John Carlson, Chair
William Bishop, Andrew Joyce, Yuko Kidoguchi, Toshio Nagase, Takeo Morooka, Byron Sigel, Vice Chairs
ACCJ Healthcare Committee
NOTE 1: This event is ON THE RECORD.
NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins.
NOTE 3: If you are driving to the Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,100 yen parking fee will apply.